Alexander Link on Muck Rack

Alexander Link

As seen in: Nature, Journal of Clinical Pathology, MDPI, MarketScreener, Nordbayerischer Kurier, Clinical Gastroenterology and Hepatology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexander

Contact Alexander, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Appointment of Chief Financial Officer and Board Changes

|
By Alexander Link, Alan Malus, will replace Mr
| MarketScreener
4basebio PLC ("4basebio" or the "Company") Appointment of Chief Financial Officer and Board Changes · Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raised Cambridge, UK, 14 May 2026 - 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the appointment of Richard Bungay as Chief Financial...
Open in Who Shared View Duplicates (98) Issue with article?

Wann macht welche Krebsvorsorge Sinn?

|
By Alexander Link
| Nordbayerischer Kurier
Telefonaktion Wann macht welche Krebsvorsorge Sinn? Alexander Link 12.04.2026 - 07:00 Uhr Zwei Ärzte, die Experten des Fachgebiets sind, beantworten am Dienstag, 14. April, von 18 bis 19 Uhr bei unserer Telefonaktion Fragen zum Thema „Wenn Krebs in der Familie liegt“.
Open in Who Shared Issue with article?

Combining tissue-derived microRNAs with clinical risk models for prediction of HCC recurrence after liver transplantation: A proof-of-concept study - Scientific Reports

|
By Theresa Lederer, Konrad Lehr, Cosima Thon, Emily Hoffmann, Wolfgang Roll, Florian Rennebaum, Haluk Morgul, Max Masthoff, Osman Öcal, Jonel Trebicka, Moritz Wildgruber, Alexander Link, Philipp Schindler, Stefanie Bobe, Kim Falkenberg
| Nature
Abstract To evaluate the utility of microRNAs (miRNAs) integrated with current clinical risk models as predictive models for hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). This retrospective proof-of-concept study included 20 patients with HCC who underwent LT between 2007 and 2021 (n = 10 recurrent, n = 10 5-year recurrence-free).
Open in Who Shared Issue with article?
See all 10 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Alexander

Contact Alexander, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified